Amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease patients treated with bapineuzumab: A retrospective analysis

BACKGROUND: Amyloid-related imaging abnormalities (ARIA) have been reported in Alzheimer’s disease (AD) patients treated with bapineuzumab, a humanized monoclonal antibody to amyloid-β. ARIA includes MRI signal abnormalities suggestive of vasogenic edema and sulcal effusions (ARIA-E) and hemosiderin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Sperling, Reisa, Salloway, Stephen, Brooks, David J., Tampieri, Donatella, Barakos, Jerome, Fox, Nick C., Raskind, Murray, Sabbagh, Marwan, Honig, Lawrence S., Porsteinsson, Anton P., Lieberburg, Ivan, Arrighi, H. Michael, Morris, Kristen A., Lu, Yuan, Liu, Enchi, Gregg, Keith M., Brashear, Robert H., Kinney, Gene G., Black, Ronald, Grundman, Michael
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063417/
https://ncbi.nlm.nih.gov/pubmed/22305802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(12)70015-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares